The persistence of high serum CXCL10 levels indicates that prolonged disease activity might accelerate functional β‐cell impairment in patients with acute‐onset type 1 diabetes or slowly progressive type 1 diabetes. Here, CXCL10 is linked to type 1 diabetes mellitus.